Morbidity & Mortality Across the CKD Continuum:
Can A Renewed Focus on Anemia Improve Outcomes?


ASN Renal Week
San Diego, CA, November, 2003
Introduction
Robert Toto, MD and Hannelore Hampl, MD
International Comparison of Practices and Outcomes: DOPPS Evaluation of Differences
Ronald Pisoni, PhD, MS.

Factors Other Than Anemia Affecting Outcomes in CKD: Would Earlier Intervention Actually Improve Outcomes?
Annamaria Kausz, MD, MS.

The Cardio-Renal Anemia Problem
Jerry Yee, MD
Iron and Anemia Managment:
A Double-Edged Sword

Jay Wish, MD
Questions and Answers
Speakers and moderator



  
Hannelore Hampl, MD
Professor of Medicine and Nephrology. KfH Kuratorium für Dialyse un Nierentransplantation, KfH Nierenzentrum, Berlin, Germany


Annamaria Kausz, MD, MS
Assistant Professor of Medicine
Division of Nephrology
Tufts-New England Medical Center
Boston, Massachussetts

Ronald Pisoni, PhD, MS
Director of Analytic Support
University Renal Research & Education Association
Ann Arbor, Michigan

Robert Toto, MD
Clinical Professor
Internal Medicine - Nephrology
Southwestern Medical School
Dallas, Texas

Jay Wish, MD
Professor of Medicine & Coordinator
Patient-Based Program
Case Western Reseve University
Cleveland, Ohio

Jerry Yee, MD
Medical Director
Division of Nephrology
Henry Ford Hospital
Detroit, Michigan



This group of talks is accredited for up to 2.0 CME Category 1 credits by the American Society of Nephrology. This group of talks has a single post-test, which must be completed along with an evaluation form to obtain Category 1 credit. The links to the post-test appear on the individual talk pages.
Date of Web Release: February 1, 2004
CME Credit Eligible Through: May 1, 2005
CME Category 1 Credits/Completion Time: 2.0
Target Audiences: Nephrology Board and Recertification candidates practicing nephrologists and internists.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations.
ACCREDITATION AND DESIGNATION STATEMENTS:
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Nephrology designates this educational activity for a maximum of 2.0 hours of category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA category 1 credit.
SPONSORSHIP / SUPPORT :
This official evening symposium was sponsored by an educational grant from Amgen Laboratories, Inc.
FACULTY DISCLOSURE STATEMENTS :
American Society of Nephrology as well as HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. Speaker disclosures are posted on each individual talk page.
DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.
DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.

For any questions concerning this specific activity please send an email to or email@asn-online.org, or call HDCN at 630-325-3276.

For any general questions concerning ASN CME, please contact the American Society of Nephrology.